| GASTRIC ULCERS |
|
|
|
|
|
|
|
|
| • | H.
pylori identified in 65% to 75% of |
||||||
| patients
with non-NSAID use |
|||||||
| • | 5% -
25% of patients taking ASA/NSAID |
||||||
| develop
gastric ulcers (inhibits synthesis of |
|||||||
| prostaglandin
which is critical for mucosal |
|||||||
| defense) |
|||||||
| • | Malignancy
cause of |
||||||